Immunostaining of postmortem tissue from COVID-19 patients showed that in secondary lymph nodes, SARS-CoV-2 can infect ACE2-expressing resident CD169+ macrophages that, in turn, are stimulated to produce IL-6 levels [81]. The gene discussed is IL6; the disease is COVID-19.